Structure-based design of novel benzoxazinorifamycins with potent binding affinity to wild-type and rifampin-resistant mutant Mycobacterium tuberculosis RNA polymerases. [electronic resource]
- Journal of medicinal chemistry Apr 2012
- 3814-26 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't